ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Clinical trial NCT06680661 · RECRUITING

Trial details

NCT number: NCT06680661
Sponsor: Leland Metheny
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Lymphatic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndromes Myelodysplastic Syndrome Other Chronic Myelomonocytic Leukemia Lymphoma Hodgkin Lymphoma

Start date: 2025-02-25
Primary completion: 2027-10-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.